2025 Agenda

The Nineteenth Annual Boot Camp

Courses will begin at 8:30 am Saturday June 14, 2025 and 8:30 am Sunday June 15, 2025

Boston Convention and Exhibition Center

SESSION 1:

Opening Remarks, Program Overview

SESSION 2:

Crafting an Exit Strategy to Satisfy Stakeholders

Identifying optimal exit timing and valuation while balancing stakeholder interests of customers, investors and acquirers.

SESSION 3:

Assessing if You Have a Project, Product or Fundable Company

This session provides a framework to determine if your company is a project, product or platform based on IP foundations. Projects offer incremental improvements suited for licensing. Products enhance existing solutions but face adoption barriers. Fundable companies launch new categories poised for investment. We explore how these categories impact commercial potential and strategic value.

SESSION 4:

Crafting Winning Business Plans and Investor Pitches

Covers best practices for creating compelling business plans and investment pitches tailored to audience needs, including problem/solution messaging, business model viability, team expertise and presentation tips.

The session provides a framework for developing a pitch to investors/partners, and the essentials of a business plan.

SESSION 5:

Translating Strategy into Execution with a Target Product Profile (TPP)

Details how a Target Product Profile bridges strategy and execution by outlining product specifications to meet clinical, customer, and market needs while aligning development, regulatory, pricing, IP, and commercialization efforts.

This session provides the format and walks the student how to prepare one for their firm.

SESSION 6:

Navigating Coding Systems and Optimizing Pricing and Reimbursement

Reviews coding frameworks and pricing dynamics in regulated markets to equip entrepreneurs with knowledge on analyzing pricing potential, securing reimbursement, and planning profitable pricing strategies.

SESSION 7:

Demystifying Regulatory Pathways for Market Entry

Simplified overview of market entry requirements, highlighting product classification, clinical trial pathways, regulatory timelines/submissions, and tools like Product Development Plans to enable informed strategic planning.

SESSION 8:

Intellectual Property Mastery: From Fundamentals to Strategic Defense

Actionable best practices around patents, IP strategy development and communicating IP value to safeguard inventions, gain exclusivity, attract funding, and sustain competitive positioning.

SESSION 9:

Expert Q&A – Applying Frameworks to Your Venture

Interactive forum to get targeted advice from seasoned industry veterans on applying covered methodologies/frameworks to address participant’s specific innovation challenges.

SESSION 10:

Building an Effective Board and Managing the Relationship

Guidance on best practices for composing and leveraging boards of directors to effectively govern startups, emphasizing mutually accountable culture, balanced compositions, and navigating governance complexities.

SESSION 11:

De-Risking through Strategic Alliances

Illustrates how start-ups can enhance credibility, accelerate momentum, and reduce perceived risk by strategically “borrowing” established brands’ reputations via complementary partnerships.

SESSION 12:

Developing Your Investment Pitch (Homework)

Assignment to craft a compelling investment pitch based on covered fundraising best practices and receive expert feedback.

SESSION 13:

Presenting Your Pitch for Expert Feedback

Entrepreneurs present their full investment pitch developed as homework to get direct input from industry experts and investors in an interactive workshop format.

SESSION 14:

Building an Entrepreneurial Management Team

Explores team assembly challenges across startup stages through CEO and VC perspectives, emphasizing how executive team building and evolution impacts funding decisions and probability of success.

SESSION 15:

Building Your Capitalization Strategy

Details early startup financing instruments and sources, including grants, angels, VCs, and partnerships. Reviews how to strategically fund innovation by understanding motivations of diverse investor types.

– Non-Dilutive Funding – NIH

– Angels

– Corporate Venture Capital

– Venture Capital

– Corporate Partners

SESSION 16:

Pre-seed/Seed Funding Pitch

Entrepreneurs pitch and get feedback from investor panel on expectations, objections, and handling early startup fundraising and valuation dynamics.

SESSION 17:

Early-Stage Funding Pitch

Later stage entrepreneurs receive investor feedback on presenting more advanced funding requests, including satisfying broader corporate partnership interests requisite at Series A/B rounds.

SESSION 18:

Managing Media Relations

Highlights importance of crafting communications on biomedical advancements for mainstream consumption across digital channels to raise awareness, educate markets, and manage public perceptions.

SESSION 19:

Structuring and Financing Your Venture

Legal advisor reviews implications of entity structuring, governance, equity moves, and exit scenarios across startup stages to equip leadership with operational, financing, and capitalization acumen.

SESSION 20:

Program Wrap-up and Conclusion

Register Now!

Saturday June 14 – Sunday June 15, 2025

Boston Convention and Exhibition Center

Add this course to your
BIO International Registration

Register Now!

Boston Convention and Exhibition Center

Add this course to your
BIO International Registration

2025 AGENDA 2025 PRESENTATIONS HISTORY PREV. CAMPS RESOURCES